Universe Pharmaceuticals INC (UPC)

NASDAQ: UPC · Real-Time Price · USD

4.270

-0.310 (-6.77%)

At close: Sep 1, 2026, 4:00 PM EDT

5.95

+1.68 (39.34%)

After-hours: Sep 1, 2026, 7:59 PM EDT

UPC Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	17.74	17.86	23.02	32.31	40.14	47.98
Revenue Growth	-8.04%	-22.44%	-28.74%	-19.52%	-16.34%	56.27%
Cost of Revenue	11.26	11.56	16.95	21.99	18.25	22.66
Gross Profit	6.48	6.3	6.07	10.32	21.89	25.33
Selling, General & Admin	7.9	8.55	11.06	9.33	21.27	6.17
Research & Development	0.67	0.67	3.03	4.86	7.64	5.47
Other Operating Expenses	-	-	0	0.1	-	0.1
Operating Expenses	8.57	9.22	14.09	14.28	28.91	11.74
Operating Income	-2.09	-2.92	-8.02	-3.97	-7.02	13.59
Interest Expense	-0.29	-0.29	-0.3	-0.19	-0.2	-0.15
Interest & Investment Income	0.06	0.06	0.03	0.03	0.04	0.29
Earnings From Equity Investments	0.07	0.07	0.03	0.03	0.04	0.03
Other Non Operating Income (Expenses)	0.31	-0.59	0.15	-0.24	0.05	-0.08
EBT Excluding Unusual Items	-1.94	-3.67	-8.12	-4.33	-7.09	13.68
Gain (Loss) on Sale of Assets	-0	-0	-0	-0	-0	-0
Pretax Income	-1.94	-3.67	-8.12	-4.33	-7.09	13.68
Income Tax Expense	-	-	0.61	2.25	0.82	2.36
Net Income	-1.94	-3.67	-8.73	-6.58	-7.91	11.32
Net Income to Common	-1.94	-3.67	-8.73	-6.58	-7.91	11.32
Net Income Growth	-	-	-	-	-	49.77%
Shares Outstanding (Basic)	1	0	0	-	-	-
Shares Outstanding (Diluted)	1	0	0	-	-	-
Shares Change	204.86%	3174.93%	-	-	-	-
EPS (Basic)	-3.45	-8.06	-626.96	-	-	-
EPS (Diluted)	-3.45	-8.06	-626.96	-	-	-
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Free Cash Flow	-12.39	-5.32	-9.75	1.07	-1.4	-15.59
Free Cash Flow Per Share	-22.00	-11.67	-700.61	-	-	-
Gross Margin	36.52%	35.28%	26.37%	31.93%	54.53%	52.78%
Operating Margin	-11.78%	-16.33%	-34.83%	-12.28%	-17.49%	28.32%
Profit Margin	-10.95%	-20.56%	-37.90%	-20.37%	-19.70%	23.59%
Free Cash Flow Margin	-69.85%	-29.78%	-42.36%	3.32%	-3.48%	-32.48%
EBITDA	-1.61	-2.4	-7.53	-3.46	-6.49	14.04
EBITDA Margin	-9.08%	-13.43%	-32.72%	-10.70%	-16.16%	29.25%
D&A For EBITDA	0.48	0.52	0.49	0.51	0.53	0.45
EBIT	-2.09	-2.92	-8.02	-3.97	-7.02	13.59
EBIT Margin	-11.78%	-16.33%	-34.83%	-12.28%	-17.49%	28.32%
Effective Tax Rate	-	-	-	-	-	17.24%
Advertising Expenses	-	2.57	5.27	4.76	-	1.33

SEC Filings: 10-K · 10-Q